hGH fragment raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-07-28. Anything still debated is marked as such rather than presented as settled.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from a fragment of human growth hormone |
| Sequence basis | hGH residues 176-191 | Commonly described as a 16-amino-acid fragment |
| Appearance | White to off-white powder | Typical for lyophilized research peptides |
| Solubility | Soluble in water or aqueous buffer | Exact solubility depends on pH and purity |
| Common synonyms | AOD9604; hGH 176-191 | Spelling and punctuation vary across sources |
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
== Q == QEEG (Quantitative Electroencephalography) A technique that analyzes EEG data using mathematical algorithms and statistical comparisons to identify abnormalities in brainwave activity. Used in research, clinical diagnostics, and neurofeedback. Quadrantanopia A type of partial vision loss affecting a quarter of the visual field, usually resulting from damage to the optic radiations or visual cortex. Quadriplegia Paralysis affecting all four limbs, often due to cervical spinal cord injury or disease. Also known as tetraplegia. Quantal neurotransmitter release The process by which neurotransmitters are released in discrete packets (quanta) from synaptic vesicles. Each quantum represents the contents of one vesicle. Quiescent state A resting or inactive phase of a neuron or glial cell in which there is minimal metabolic or electrical activity. Relevant in stem cell research and neuronal excitability. Quinine An alkaloid that blocks certain ion channels, including voltage-gated potassium channels. Used experimentally in neurophysiology and to treat malaria.
Within the empire, 65% of the territory and 62% of the population belonged to Prussia. The Treaty of Versailles at the end of World War I stripped the former German Empire of 12 to 13 percent of its land area and population, the majority of it from Prussia. Only Alsace–Lorraine, which had never attained full statehood, was wholly lost to Germany. The new Weimar Republic remained federal in nature, with a total of 17 states. Seven small states in east-central Germany consolidated into Thuringia in 1920, Coburg chose to merge into Bavaria (also in 1920), and Prussia absorbed Pyrmont and Waldeck (1921 and 1929). During the Weimar period, there were a number of unsuccessful proposals to make radical changes to Germany's state structure, seven short-lived unrecognized states, four of them self-declared soviet republics during the German revolution of 1918–1919, plus two separatist republics in the Rhineland in 1923/24. After the Nazi Party seized power in January 1933, the states were gradually abolished and reduced to provinces under the Nazi regime via the Gleichschaltung process, as the states administratively were largely superseded by the Nazi Gau system. Three changes are of particular note: on 1 January 1934, Mecklenburg-Schwerin was united with neighbouring Mecklenburg-Strelitz; and, by the Greater Hamburg Act (Groß-Hamburg-Gesetz) of 1937, the territory of the city-state was extended, while Lübeck lost its independence and became part of the Prussian province of Schleswig-Holstein.
Industry, constituting 19.74% of GDP and 24% of total employment, is the second-largest sector. Large-scale manufacturing (LSM) dominates, representing 12.2% of GDP, with cement production thriving due to demand from Afghanistan and the domestic real estate sector. In 2013, Pakistan exported 7,708,557 metric tons of cement, with an installed capacity of 44,768,250 metric tons. The textile industry, a key player in Pakistan's manufacturing, contributes 9.5% to GDP and employs around 15 million people. As of 2022, Pakistan ranks seventh globally in cotton production, with substantial spinning capacity, making it a major exporter of textile products in Asia. China has been a significant buyer of Pakistani textiles, importing US$1.527 billion worth of textiles in 2012.
Sources: en.wikipedia.org
. Whenever the integer nature of the number of agents is evident (populations with fewer than tens of thousands of individuals), inherent fluctuations in the disease spreading process caused by discrete agents result in uncertainties. In this scenario, the evolution of the disease predicted by compartmental equations deviates significantly from the observed results. These uncertainties may even cause the epidemic to end earlier than predicted by the compartmental equations. As a special case, one obtains the usual logistic function by assuming
He stated STURP lacked expertise in medieval art techniques, and their findings need reassessment due to 35 years of development in microscopy. Andrea Nicolotti declared "We have known for four centuries that the image on the Shroud is flat, like a rectangular projection, and could not have been created by contact with a three-dimensional body."
== Critical reception == Carmen Keats from Melody Maker wrote, "This time, though, I can sort of stand the relentless disco beat because of the candy-sad words, which are nicely perceptive and suit the fairground kerfuffle." Chris Gerard from Metro Weekly described the song as an "uber-catchy pop masterpiece" with a "soulful chorus". Pan-European magazine Music & Media viewed it as "a highly contagious, straight pop song that immediately sticks in your head. Their best choice for a single to date."
Integrative, multi-locus studies have prompted major revisions of several lichen families and genera. Two examples illustrate the impact of these studies: the re-circumscription of the family Graphidaceae and of the family Ramalinaceae. Graphidaceae—the script lichen family—contains more than 2,000 mostly tropical species. Traditional taxonomy centred on fruiting body shape and a few microscopic characters. A five-locus phylogeny (Rivas-Plata and Lumbsch 2011) showed that many characters had evolved convergently. Slit-like versus rounded discs arose repeatedly, so genera built on those traits mixed unrelated species. Molecular results led to a wholesale recircumscription: several traditional genera were divided and new ones erected to reflect monophyletic clades. For instance, the broad Graphis was split into several smaller, genetically and chemically homogeneous genera. This process was facilitated by projects such as Ticolichen (a tropical lichen inventory project) which combined fieldwork, morphology, chemistry, and DNA sequencing to tackle these revisions. The outcome is a more natural scheme: genera now align with monophyletic clades, even when outwardly dissimilar species must be grouped together. The revision greatly increased recognized genera and species, exposing hidden diversity in tropical crustose lichens. Another major revision, in this case of a mostly temperate/tropical group, was carried out by Kistenich and colleagues (2018) on the family Ramalinaceae. The family had about 40 genera of uncertain affinity, several delimited by only one or two traits.
Sources: en.wikipedia.org
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.
It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.
It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.